BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 180 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,524,227 | -17.6% | 30,351 | +3.7% | 0.01% | -9.1% |
Q2 2023 | $1,849,927 | +42.6% | 29,271 | +1.5% | 0.01% | +22.2% |
Q1 2023 | $1,297,512 | +4.8% | 28,840 | +2.0% | 0.01% | 0.0% |
Q4 2022 | $1,238,333 | -33.7% | 28,266 | -0.4% | 0.01% | -35.7% |
Q3 2022 | $1,869,000 | +32.3% | 28,369 | +1.4% | 0.01% | +40.0% |
Q2 2022 | $1,413,000 | -23.9% | 27,968 | -3.7% | 0.01% | 0.0% |
Q1 2022 | $1,856,000 | -44.3% | 29,051 | -6.6% | 0.01% | -41.2% |
Q4 2021 | $3,331,000 | +1.2% | 31,096 | -2.9% | 0.02% | -5.6% |
Q3 2021 | $3,293,000 | +14.2% | 32,027 | -2.3% | 0.02% | +80.0% |
Q2 2021 | $2,884,000 | -15.5% | 32,788 | -6.5% | 0.01% | -16.7% |
Q1 2021 | $3,411,000 | -14.0% | 35,082 | -0.8% | 0.01% | -20.0% |
Q4 2020 | $3,967,000 | +29.3% | 35,373 | +6.9% | 0.02% | 0.0% |
Q3 2020 | $3,068,000 | +18.5% | 33,091 | -0.3% | 0.02% | +25.0% |
Q2 2020 | $2,588,000 | +39.6% | 33,180 | +4.7% | 0.01% | +20.0% |
Q1 2020 | $1,854,000 | -24.3% | 31,696 | +3.7% | 0.01% | +11.1% |
Q4 2019 | $2,450,000 | +8.1% | 30,579 | -0.8% | 0.01% | 0.0% |
Q3 2019 | $2,266,000 | -22.6% | 30,837 | -0.7% | 0.01% | -18.2% |
Q2 2019 | $2,929,000 | +38.7% | 31,051 | +17.8% | 0.01% | +37.5% |
Q1 2019 | $2,111,000 | +43.8% | 26,367 | -3.1% | 0.01% | +33.3% |
Q4 2018 | $1,468,000 | -31.4% | 27,222 | -0.8% | 0.01% | -14.3% |
Q3 2018 | $2,141,000 | +25.2% | 27,432 | +1.8% | 0.01% | +16.7% |
Q2 2018 | $1,710,000 | -31.4% | 26,937 | -0.9% | 0.01% | -33.3% |
Q1 2018 | $2,493,000 | +15.4% | 27,189 | -5.1% | 0.01% | +28.6% |
Q4 2017 | $2,161,000 | +19.1% | 28,651 | +10.0% | 0.01% | +16.7% |
Q3 2017 | $1,814,000 | +48.6% | 26,043 | +8.1% | 0.01% | +50.0% |
Q2 2017 | $1,221,000 | +107.3% | 24,096 | +63.6% | 0.00% | +100.0% |
Q1 2017 | $589,000 | +82.4% | 14,728 | +28.0% | 0.00% | +100.0% |
Q4 2016 | $323,000 | -99.9% | 11,507 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $342,649,000 | +46.9% | 11,537 | +0.1% | 0.00% | 0.0% |
Q2 2016 | $233,280,000 | +135.6% | 11,520 | +110.0% | 0.00% | – |
Q1 2016 | $99,000,000 | -31.7% | 5,486 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $145,000,000 | +123831.6% | 5,486 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $117,000 | -99.9% | 5,496 | +0.1% | 0.00% | 0.0% |
Q2 2015 | $145,430,000 | – | 5,490 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |